Details for Patent: 11,162,500

Which drugs does patent 11,162,500 protect, and when does it expire?

Patent 11,162,500 protects PARSABIV and is included in one NDA.

This patent has forty-seven patent family members in thirty-eight countries.

Drugs Protected by US Patent 11,162,500

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kai Pharms Inc	PARSABIV	etelcalcetide	SOLUTION;INTRAVENOUS	208325-001	Feb 7, 2017		RX	Yes	Yes	11,162,500		Y
Kai Pharms Inc	PARSABIV	etelcalcetide	SOLUTION;INTRAVENOUS	208325-002	Feb 7, 2017		RX	Yes	Yes	11,162,500		Y
Kai Pharms Inc	PARSABIV	etelcalcetide	SOLUTION;INTRAVENOUS	208325-003	Feb 7, 2017		RX	Yes	Yes	11,162,500		Y

International Family Members for US Patent 11,162,500

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	096773
Australia	2014302122
Brazil	112015032615